Anders Holt

667 total citations
41 papers, 385 citations indexed

About

Anders Holt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anders Holt has authored 41 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Anders Holt's work include Heart Failure Treatment and Management (11 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Anders Holt is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Anders Holt collaborates with scholars based in Denmark, United Kingdom and New Zealand. Anders Holt's co-authors include Morten Lamberts, Gunnar Gislason, Morten Schou, Christian Torp‐Pedersen, Lars Køber, Bochra Zareini, Emil Loldrup Fosbøl, Charlotte Andersson, Matthew Phelps and Thomas Alexander Gerds and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and European Heart Journal.

In The Last Decade

Anders Holt

33 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Holt Denmark 10 197 83 81 43 42 41 385
Daozheng Huang China 12 37 0.2× 42 0.5× 80 1.0× 36 0.8× 66 1.6× 20 364
Ruxandra Christodorescu Romania 11 139 0.7× 17 0.2× 23 0.3× 23 0.5× 26 0.6× 35 328
Anders Westanmo United States 10 38 0.2× 37 0.4× 41 0.5× 23 0.5× 36 0.9× 26 314
Hamza H. Awad United States 10 232 1.2× 41 0.5× 13 0.2× 71 1.7× 27 0.6× 18 484
Camilla Koch Ryrsø Denmark 11 109 0.6× 25 0.3× 63 0.8× 48 1.1× 57 1.4× 30 417
Martin Lindgren Sweden 12 266 1.4× 22 0.3× 18 0.2× 38 0.9× 12 0.3× 36 441
Aarti Thakkar United States 9 110 0.6× 9 0.1× 58 0.7× 53 1.2× 40 1.0× 21 325
Cibele Isaac Saad Rodrigues Brazil 10 65 0.3× 24 0.3× 37 0.5× 11 0.3× 20 0.5× 52 265
Keshav R. Nayak United States 12 259 1.3× 33 0.4× 30 0.4× 26 0.6× 21 0.5× 25 517
Mark Findlay United Kingdom 9 89 0.5× 18 0.2× 22 0.3× 84 2.0× 27 0.6× 20 358

Countries citing papers authored by Anders Holt

Since Specialization
Citations

This map shows the geographic impact of Anders Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Holt more than expected).

Fields of papers citing papers by Anders Holt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Holt. The network helps show where Anders Holt may publish in the future.

Co-authorship network of co-authors of Anders Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Holt. A scholar is included among the top collaborators of Anders Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Holt. Anders Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strange, Jarl Emanuel, Anders Holt, Gunnar Gislason, et al.. (2025). Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: evidence from a nationwide nested case–control study paralleled with matched experimental models. European Heart Journal Open. 5(3). oeaf021–oeaf021. 1 indexed citations
2.
Malik, Mariam Elmegaard, Simon Bo Larsen, Caroline Sindet‐Pedersen, et al.. (2025). Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study. European Heart Journal.
3.
Christensen, Daniel Mølager, Christian Torp-Pedersen, Tor Biering‐Sørensen, et al.. (2025). Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failure. Heart. 111(13). 609–617.
4.
Olesen, Jonas Bjerring, et al.. (2025). Clinical consequences of smartwatch implementation in a cardiology outpatient clinic. PubMed. 72(9). 1–10.
5.
Strange, Jarl Emanuel, Caroline Sindet‐Pedersen, Anders Holt, et al.. (2024). Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study. International Journal of Cardiology. 406. 132001–132001. 1 indexed citations
6.
Holt, Anders, Jarl Emanuel Strange, Anne-Marie Schjerning, et al.. (2024). Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. European Heart Journal. 45(6). 475–484. 16 indexed citations
7.
Holt, Anders, Patricia McGettigan, & Morten Lamberts. (2024). Unmeasured confounding is always unnerving: cannabis and cardiovascular risk. European Heart Journal. 45(28). 2574–2575. 1 indexed citations
8.
Strange, Jarl Emanuel, Anders Holt, Lars Køber, et al.. (2023). Patient Mortality Following New-Onset Heart Failure Stratified by Cancer Type and Status. European Journal of Heart Failure. 25(10). 1859–1867. 4 indexed citations
9.
Holt, Anders, Andrew Kerr, Sue Crengle, et al.. (2023). Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease. European Journal of Preventive Cardiology. 31(2). 218–227. 1 indexed citations
10.
Sindet‐Pedersen, Caroline, Daniel Mølager Christensen, Thomas Kümler, et al.. (2023). High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020. European Heart Journal - Quality of Care and Clinical Outcomes. 10(3). 256–264. 4 indexed citations
11.
Lamberts, Morten, et al.. (2023). Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study. European Heart Journal. 44(Supplement_2). 1 indexed citations
12.
Strange, Jarl Emanuel, Caroline Sindet‐Pedersen, Anders Holt, et al.. (2023). Nursing Home Admission Following Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 16(2). 179–188. 5 indexed citations
13.
Zareini, Bochra, Paul Blanche, Anders Holt, et al.. (2022). The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes. Clinical Research in Cardiology. 111(4). 460–468. 1 indexed citations
14.
Holt, Anders, Morten Lamberts, Gunnar Gislason, et al.. (2021). Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017. European Heart Journal - Quality of Care and Clinical Outcomes. 8(7). 750–760. 21 indexed citations
15.
Holt, Anders, Jarl Emanuel Strange, Peter Rasmussen, et al.. (2021). Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran. The American Journal of Medicine. 135(5). 595–602.e5. 9 indexed citations
16.
Strange, Jarl Emanuel, Anders Holt, Paul Blanche, et al.. (2021). Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study. European Heart Journal. 42(30). 2899–2908. 11 indexed citations
17.
Holt, Anders, Gunnar Gislason, Morten Schou, et al.. (2020). New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. European Heart Journal. 41(32). 3072–3079. 68 indexed citations
19.
Holt, Anders, et al.. (2020). Influence of inhibitors of the renin–angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients. Journal of Hypertension. 38(8). 1612–1613. 8 indexed citations
20.
Zareini, Bochra, Rasmus Rørth, Anders Holt, et al.. (2018). POOR PROGNOSIS FOLLOWING DIABETES MELLITUS IN PATIENTS WITH HEART FAILURE: A NATIONWIDE COHORT STUDY. Journal of the American College of Cardiology. 71(11). A675–A675. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026